Was most pronounced in ATRA-treated mice. Furthermore, the epidermal surface seemed notably scaly soon after application with the synthetic RARc agonist and ATRA (Figure 2).RAR-RXR Signaling Pathways Modify Epidermal Barrier HomeostasisWe next investigated the expression of numerous genes with considerable functions in epidermal barrier homeostasis uponPLOS A single | plosone.orgtreatment with receptor-specific agonists and antagonists. As shown in Table 1 and Figure 3, application of your synthetic RARc agonist and ATRA each induced genes involved in barrier function (Abca12, Flg, Lor, Spink5, Krt16, Hbegf). On the other hand, mRNA levels of genes implicated in ceramide metabolism (Acer1, Gba, Ugcg) or cholesterol synthesis (Hmgcs2) were mainly decreased or unaffected by the treatment. When compared with RARc ligand application, expression of these genes was markedly downregulated (many times below detection limit) when mice have been treated together with the synthetic RARa agonist (Table 1, Figure three). Noticeably, the same expression profile was observed following application of RAR or RXR antagonists. Remedy using the RXR agonist and RARa- and RARc-specific antagonists resulted in inconsistent gene expressions with an increase of some genes (Spink5, Flg, Klk7) and decrease of other genes (Abca12, Krt16, Ugcg) involved in epidermal function (Table 1, Figure 3). Krt6b expression was below the limit of detection in all groups (not shown).Differential Retinoid Signaling in SkinTable 2. Fold adjust of retinoid metabolism-related gene expression in skin of mice immediately after two weeks topical remedy with retinoid receptor-specific agonists.Agonists (Fold change) Gene name Retinal synthesis Beta-carotene oxygenase Brief chain dehydrogenase/reductase 16C5 Retinol dehydrogenase 10 Retinol dehydrogenase 16 Alcohol dehydrogenase 7 Retinoic acid synthesis Aldehyde dehydrogenase 1A1 Aldehyde dehydrogenase 1A2 Aldehyde dehydrogenase 1A35 Retinoid receptor Retinoic acid receptor a Retinoic acid receptor b5 Retinoic acid receptor c Retinoid X receptor a Retinoid target genes Retinoic acid degradation Cytochrome P450 26A1 Cytochrome P450 26B1 Cytochrome P450 2S1 Retinoid transport proteins Retinol binding protein 4 Cellular retinol binding protein 1 Cellular retinoic acid binding protein 1 Cellular retinoic acid binding protein 2 Fatty acid binding protein five Retinol esterification Lecithin-retinol acyltransferase Diacylglycerol O-acyltransferase Additional retinoid target genes6 Keratin four Retinoic acid receptor responder 2 Heparin-binding EGF-like growth factor1 two 3 4SymbolRARaRARcATRARXRBco2 Sdr16c5 Rdh10 Rdh16 AdhUDL UDL 0.5-Fluoro-1,3-dimethyl-2-nitrobenzene structure 0160.Formula of 3-Bromo-4-chloro-5-fluoroaniline 0031 49361281 0.PMID:26644518 260.1 UDL# 0.0460.009* UDLUDL 0.660.1 1.560.11 1.360.three 1.860.UDL 9.461.330561921 0.960.1 0.660.1# 0.560.0.760.1* 2.560.3 two.860.260.1*Aldh1a1 Aldh1a2 Aldh1a0.760.1 0.760.2 160.0.660.1 3.460.51 0.0260.0081 five.860.41 1.460.1* 0.960.three 1.460.0.360.1 two.460.3# 0.960.Rara Rarb Rarg RxraUDL* UDL1 UDL1 0.00260.0.360.1 1.160.two 1.160.1 0.960.0.760.1 0.660.1* 0.960.1 160.Cyp26a1 Cyp26b1 Cyp2sUDL 0.00360.003 UDL#1965.4 1360.five 0.960.141061611 2996541 0.660.1.560.3 1.660.two 0.960.1Rbp4 Rbp1 Crabp1 Crabp2 FabpUDL 0.0260.UDL 1.460.two 160.two 1.560.2* 1.960.4 2.360.21 1.560.UDL 2.860.2 1.760.3 260.21 two.260.1 260.11 0.460.11 316766791 1.360.three 260.2*70.760.1 1.860.2* 0.860.04 1.260.0.0260.01# 0.000760.00031 1060.81 0.0260.0071 UDLLrat Dgat160.1 0.260.Krt4 Rarres2 HbegfUDL UDL 0.0360.01*647066461 1.860.two 2.760.7.763 1.660.two 0.360.BMS753; BMS961; all-trans retinoic acid; LG268;.